Reason: CGMP Deviations
Distributed: Product was distributed to two accounts in NC and MIReason: Labeling: Incorrect or Missing Package Insert
Distributed: OH, IL, NJReason: Incorrect product concentration on the overwrap label: The overwrap label incorrectly identified the product strength as 4 mg / 250 mL; however, the primary bag label correctly identified the product strength as 8 mg / 250 mL.
Distributed: Nationwide in the USAReason: Marketed without an approved NDA/ANDA: Product contains tianeptine, a substance not FDA-approved for any medical use in the United States.
Distributed: Nationwide in the USAReason: Marketed without an approved NDA/ANDA: Product contains tianeptine, a substance not FDA-approved for any medical use in the United States.
Distributed: Nationwide in the USAReason: Marketed without an approved NDA/ANDA: Product contains tianeptine, a substance not FDA-approved for any medical use in the United States.
Distributed: Nationwide in the USAReason: CGMP Deviations: Potential Glass and Silicone particulates in product
Distributed: Nationwide in the USReason: CGMP Deviations: Potential Glass and Silicone particulates in product
Distributed: Nationwide in the USReason: CGMP Deviations: Potential Glass and Silicone particulates in product
Distributed: Nationwide in the USReason: CGMP Deviations: Potential Glass and Silicone particulates in product
Distributed: Nationwide in the US